Rank | Gene Set | Z-score |
---|---|---|
1 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 6.06193732 |
2 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 6.05934593 |
3 | locomotory exploration behavior (GO:0035641) | 5.90237410 |
4 | neuronal action potential propagation (GO:0019227) | 5.76867231 |
5 | synaptic vesicle maturation (GO:0016188) | 5.69075078 |
6 | vocalization behavior (GO:0071625) | 5.48922195 |
7 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 5.41031772 |
8 | synaptic vesicle exocytosis (GO:0016079) | 5.40114235 |
9 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 5.28468483 |
10 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 5.27771052 |
11 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 5.12453612 |
12 | regulation of synaptic vesicle exocytosis (GO:2000300) | 5.00668697 |
13 | glutamate secretion (GO:0014047) | 4.99965058 |
14 | gamma-aminobutyric acid transport (GO:0015812) | 4.97558216 |
15 | cerebellar granule cell differentiation (GO:0021707) | 4.97545350 |
16 | neurotransmitter secretion (GO:0007269) | 4.94866228 |
17 | regulation of glutamate receptor signaling pathway (GO:1900449) | 4.90870331 |
18 | L-amino acid import (GO:0043092) | 4.87847561 |
19 | synaptic transmission, glutamatergic (GO:0035249) | 4.83168877 |
20 | glutamate receptor signaling pathway (GO:0007215) | 4.83145709 |
21 | neurotransmitter-gated ion channel clustering (GO:0072578) | 4.82017542 |
22 | neuron-neuron synaptic transmission (GO:0007270) | 4.77934656 |
23 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 4.65186178 |
24 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 4.64785879 |
25 | regulation of synapse structural plasticity (GO:0051823) | 4.46407901 |
26 | regulation of synaptic vesicle transport (GO:1902803) | 4.42882191 |
27 | potassium ion homeostasis (GO:0055075) | 4.42761268 |
28 | amino acid import (GO:0043090) | 4.39518270 |
29 | long-term memory (GO:0007616) | 4.37906254 |
30 | regulation of neuronal synaptic plasticity (GO:0048168) | 4.35464594 |
31 | protein localization to synapse (GO:0035418) | 4.34328581 |
32 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 4.32105471 |
33 | prepulse inhibition (GO:0060134) | 4.27076836 |
34 | potassium ion import (GO:0010107) | 4.27070852 |
35 | positive regulation of synapse maturation (GO:0090129) | 4.26699924 |
36 | cerebellar Purkinje cell differentiation (GO:0021702) | 4.25329129 |
37 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 4.24595638 |
38 | positive regulation of dendritic spine development (GO:0060999) | 4.22785159 |
39 | cellular potassium ion homeostasis (GO:0030007) | 4.22044274 |
40 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 4.21573320 |
41 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 4.21058783 |
42 | exploration behavior (GO:0035640) | 4.18078848 |
43 | positive regulation of membrane potential (GO:0045838) | 4.09026357 |
44 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 4.05752697 |
45 | regulation of ARF protein signal transduction (GO:0032012) | 4.05743790 |
46 | regulation of postsynaptic membrane potential (GO:0060078) | 4.01746712 |
47 | cell communication by electrical coupling (GO:0010644) | 4.01239146 |
48 | proline transport (GO:0015824) | 3.95974072 |
49 | neuromuscular process controlling posture (GO:0050884) | 3.95046321 |
50 | cellular sodium ion homeostasis (GO:0006883) | 3.94537829 |
51 | axon ensheathment in central nervous system (GO:0032291) | 3.94406738 |
52 | central nervous system myelination (GO:0022010) | 3.94406738 |
53 | long-term synaptic potentiation (GO:0060291) | 3.93476313 |
54 | neuromuscular process controlling balance (GO:0050885) | 3.90031358 |
55 | postsynaptic membrane organization (GO:0001941) | 3.89177053 |
56 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 3.88385019 |
57 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.84563449 |
58 | auditory behavior (GO:0031223) | 3.84214481 |
59 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 3.82454921 |
60 | regulation of synaptic plasticity (GO:0048167) | 3.81760715 |
61 | transmission of nerve impulse (GO:0019226) | 3.81138564 |
62 | negative regulation of dendrite morphogenesis (GO:0050774) | 3.80659595 |
63 | neurotransmitter transport (GO:0006836) | 3.79629558 |
64 | sodium ion export (GO:0071436) | 3.79093074 |
65 | behavioral response to cocaine (GO:0048148) | 3.77687982 |
66 | striatum development (GO:0021756) | 3.76681310 |
67 | neuron cell-cell adhesion (GO:0007158) | 3.73342337 |
68 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 3.72119555 |
69 | regulation of dendritic spine morphogenesis (GO:0061001) | 3.69623017 |
70 | regulation of neurotransmitter levels (GO:0001505) | 3.66237896 |
71 | long term synaptic depression (GO:0060292) | 3.64156306 |
72 | regulation of neurotransmitter secretion (GO:0046928) | 3.63633703 |
73 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 3.63574695 |
74 | layer formation in cerebral cortex (GO:0021819) | 3.58233538 |
75 | regulation of voltage-gated calcium channel activity (GO:1901385) | 3.56967893 |
76 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 3.55953502 |
77 | dendritic spine morphogenesis (GO:0060997) | 3.55078850 |
78 | neurotransmitter uptake (GO:0001504) | 3.53086208 |
79 | membrane depolarization (GO:0051899) | 3.50394175 |
80 | regulation of neurotransmitter transport (GO:0051588) | 3.49263278 |
81 | response to histamine (GO:0034776) | 3.48662751 |
82 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 3.48469951 |
83 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 3.46518676 |
84 | membrane hyperpolarization (GO:0060081) | 3.46081726 |
85 | positive regulation of neurotransmitter transport (GO:0051590) | 3.45035617 |
86 | cell differentiation in hindbrain (GO:0021533) | 3.42352274 |
87 | membrane depolarization during action potential (GO:0086010) | 3.42320482 |
88 | vesicle docking involved in exocytosis (GO:0006904) | 3.41090049 |
89 | activation of protein kinase A activity (GO:0034199) | 3.40328022 |
90 | response to auditory stimulus (GO:0010996) | 3.39303346 |
91 | mechanosensory behavior (GO:0007638) | 3.38003083 |
92 | positive regulation of neurotransmitter secretion (GO:0001956) | 3.35932513 |
93 | regulation of glutamate secretion (GO:0014048) | 3.35403955 |
94 | dendritic spine organization (GO:0097061) | 3.35003654 |
95 | acidic amino acid transport (GO:0015800) | 3.34625534 |
96 | synaptic vesicle transport (GO:0048489) | 3.32999273 |
97 | establishment of synaptic vesicle localization (GO:0097480) | 3.32999273 |
98 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.32773515 |
99 | adult walking behavior (GO:0007628) | 3.30974491 |
100 | synaptic transmission, dopaminergic (GO:0001963) | 3.29206853 |
101 | learning (GO:0007612) | 3.27828022 |
102 | neuromuscular process (GO:0050905) | 3.26686935 |
103 | regulation of synapse maturation (GO:0090128) | 3.26430910 |
104 | negative regulation of amino acid transport (GO:0051956) | 3.25424014 |
105 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 3.21750516 |
106 | cerebellar Purkinje cell layer development (GO:0021680) | 3.20205843 |
107 | glycine transport (GO:0015816) | 3.18878152 |
108 | positive regulation of synaptic transmission (GO:0050806) | 3.18593693 |
109 | regulation of exocytosis (GO:0017157) | 3.17447485 |
110 | behavioral fear response (GO:0001662) | 3.17013437 |
111 | behavioral defense response (GO:0002209) | 3.17013437 |
112 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.15769695 |
113 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 3.15208654 |
114 | * synaptic transmission (GO:0007268) | 3.14432602 |
115 | visual learning (GO:0008542) | 3.14214213 |
116 | chemosensory behavior (GO:0007635) | 3.13798900 |
117 | regulation of vesicle fusion (GO:0031338) | 3.13686708 |
118 | regulation of synaptic transmission (GO:0050804) | 3.13146935 |
119 | neuronal ion channel clustering (GO:0045161) | 3.12560436 |
120 | vesicle docking (GO:0048278) | 3.12415276 |
121 | signal release (GO:0023061) | 3.11920655 |
122 | positive regulation of dendrite development (GO:1900006) | 3.11260118 |
123 | neuromuscular synaptic transmission (GO:0007274) | 3.10987199 |
124 | response to pheromone (GO:0019236) | 3.09965645 |
125 | fear response (GO:0042596) | 3.09832232 |
126 | presynaptic membrane organization (GO:0097090) | 3.09281838 |
127 | cell communication involved in cardiac conduction (GO:0086065) | 3.08892870 |
128 | synaptic vesicle endocytosis (GO:0048488) | 3.08667373 |
129 | regulation of female receptivity (GO:0045924) | 3.06824064 |
130 | regulation of dendritic spine development (GO:0060998) | 3.04146861 |
Rank | Gene Set | Z-score |
---|---|---|
1 | EZH2_22144423_ChIP-Seq_EOC_Human | 5.76894120 |
2 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.47847244 |
3 | * SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 3.37908815 |
4 | * SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 3.30737857 |
5 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 3.28247769 |
6 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 3.12534321 |
7 | * REST_21632747_ChIP-Seq_MESCs_Mouse | 2.96567258 |
8 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.90190500 |
9 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.90190500 |
10 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.82689810 |
11 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.77267622 |
12 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.72357195 |
13 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 2.69971796 |
14 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.67605561 |
15 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.62939113 |
16 | * SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.62198881 |
17 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.52570857 |
18 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.51338690 |
19 | * REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.47352487 |
20 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.44146922 |
21 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.33810819 |
22 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.31323048 |
23 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.24307598 |
24 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.24258633 |
25 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 2.16454432 |
26 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 2.15353841 |
27 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.97816174 |
28 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.97070266 |
29 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.88837640 |
30 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.85104591 |
31 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.71517431 |
32 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.70058681 |
33 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.63656255 |
34 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.60931785 |
35 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.55633057 |
36 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.47113924 |
37 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.46574364 |
38 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.43751810 |
39 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.43115260 |
40 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.40702728 |
41 | * SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.39130131 |
42 | * ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.34991676 |
43 | * CTCF_27219007_Chip-Seq_Bcells_Human | 1.31441396 |
44 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.31295148 |
45 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.29611733 |
46 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.27699101 |
47 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.27631399 |
48 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.27011610 |
49 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.25254329 |
50 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.24880160 |
51 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.24343010 |
52 | * AR_19668381_ChIP-Seq_PC3_Human | 1.23354128 |
53 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.22597069 |
54 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.21835361 |
55 | STAT3_23295773_ChIP-Seq_U87_Human | 1.21239218 |
56 | AR_25329375_ChIP-Seq_VCAP_Human | 1.21236358 |
57 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.21127607 |
58 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.20977573 |
59 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.19157280 |
60 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.18843798 |
61 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.18421791 |
62 | P300_19829295_ChIP-Seq_ESCs_Human | 1.17161503 |
63 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.15732650 |
64 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.15331340 |
65 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.14436646 |
66 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 1.11550000 |
67 | * KDM2B_26808549_Chip-Seq_K562_Human | 1.10726817 |
68 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.10425698 |
69 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.10334580 |
70 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.09186578 |
71 | OCT4_19829295_ChIP-Seq_ESCs_Human | 1.09037553 |
72 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.08451097 |
73 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 1.07955288 |
74 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.07581188 |
75 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.07249851 |
76 | TCF4_23295773_ChIP-Seq_U87_Human | 1.06016423 |
77 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.05859012 |
78 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.05798095 |
79 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.04988355 |
80 | * SMC4_20622854_ChIP-Seq_HELA_Human | 1.04611474 |
81 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.03451982 |
82 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.02243856 |
83 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.01869562 |
84 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.00067291 |
85 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 0.99213334 |
86 | DPY_21335234_ChIP-Seq_ESCs_Mouse | 0.99021154 |
87 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 0.98926362 |
88 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.98219000 |
89 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.98167165 |
90 | * SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.97785661 |
91 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 0.97666235 |
92 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 0.97620875 |
93 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.96996249 |
94 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.96091460 |
95 | RXR_22108803_ChIP-Seq_LS180_Human | 0.95598933 |
96 | RUNX2_22187159_ChIP-Seq_PCA_Human | 0.95250518 |
97 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 0.94996143 |
98 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.94938128 |
99 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.94251343 |
100 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.94237614 |
101 | TP53_16413492_ChIP-PET_HCT116_Human | 0.94220881 |
102 | * SIN3B_21632747_ChIP-Seq_MESCs_Mouse | 0.92966263 |
103 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.92669891 |
104 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.92656720 |
105 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.92011503 |
106 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.91907090 |
107 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.91488627 |
108 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.90728600 |
109 | * KLF4_19829295_ChIP-Seq_ESCs_Human | 0.90484894 |
110 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.90286245 |
111 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 0.89793554 |
112 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.89092520 |
113 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.89001049 |
114 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.88865510 |
115 | P68_20966046_ChIP-Seq_HELA_Human | 0.88158609 |
116 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 0.87130674 |
117 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.87049456 |
118 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.84467706 |
119 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.84269958 |
120 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.83920850 |
121 | SMAD4_21741376_ChIP-Seq_ESCs_Human | 0.83462947 |
122 | RNF2_27304074_Chip-Seq_NSC_Mouse | 0.83137405 |
123 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.83047760 |
124 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.82826174 |
125 | RUNX1_26923725_Chip-Seq_HPCs_Mouse | 0.81435323 |
126 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.80817447 |
127 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.80733575 |
128 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.80422900 |
129 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.80422900 |
130 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.80289749 |
131 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.79566863 |
132 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 0.78094527 |
133 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 0.73972559 |
134 | TP53_23651856_ChIP-Seq_MEFs_Mouse | 0.73871220 |
135 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.73812579 |
136 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.73425555 |
137 | TFAP2A_17053090_ChIP-ChIP_MCF-7_Human | 0.73155854 |
138 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 0.71040820 |
139 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.70392304 |
140 | NEUROD2_26341353_ChIP-Seq_CORTEX_Mouse | 0.70149679 |
141 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 0.69198445 |
142 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.68519192 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0004859_abnormal_synaptic_plasticity | 6.65865128 |
2 | MP0002822_catalepsy | 4.56335668 |
3 | * MP0003635_abnormal_synaptic_transmissio | 4.46110469 |
4 | MP0003880_abnormal_central_pattern | 4.44901718 |
5 | MP0009046_muscle_twitch | 4.31003487 |
6 | * MP0009745_abnormal_behavioral_response | 3.80529747 |
7 | * MP0002064_seizures | 3.45975266 |
8 | * MP0002063_abnormal_learning/memory/cond | 3.45830644 |
9 | MP0004270_analgesia | 3.44640596 |
10 | * MP0002272_abnormal_nervous_system | 2.96625797 |
11 | * MP0002572_abnormal_emotion/affect_behav | 2.94868040 |
12 | MP0001968_abnormal_touch/_nociception | 2.90618861 |
13 | MP0001486_abnormal_startle_reflex | 2.77140206 |
14 | MP0008569_lethality_at_weaning | 2.58655514 |
15 | MP0002734_abnormal_mechanical_nocicepti | 2.56305129 |
16 | MP0001501_abnormal_sleep_pattern | 2.49738135 |
17 | MP0005423_abnormal_somatic_nervous | 2.39510045 |
18 | MP0001440_abnormal_grooming_behavior | 2.25733930 |
19 | MP0002736_abnormal_nociception_after | 2.23031618 |
20 | MP0002067_abnormal_sensory_capabilities | 2.19017302 |
21 | MP0004924_abnormal_behavior | 1.92228645 |
22 | MP0005386_behavior/neurological_phenoty | 1.92228645 |
23 | MP0003879_abnormal_hair_cell | 1.90647086 |
24 | MP0001970_abnormal_pain_threshold | 1.89575603 |
25 | MP0002733_abnormal_thermal_nociception | 1.89333407 |
26 | MP0002735_abnormal_chemical_nociception | 1.86338829 |
27 | MP0003329_amyloid_beta_deposits | 1.85438084 |
28 | MP0002184_abnormal_innervation | 1.81457125 |
29 | MP0002909_abnormal_adrenal_gland | 1.76902658 |
30 | * MP0002557_abnormal_social/conspecific_i | 1.69199792 |
31 | MP0001984_abnormal_olfaction | 1.63638082 |
32 | MP0004811_abnormal_neuron_physiology | 1.62288823 |
33 | MP0003123_paternal_imprinting | 1.59915321 |
34 | MP0001529_abnormal_vocalization | 1.58943504 |
35 | MP0005646_abnormal_pituitary_gland | 1.56663363 |
36 | MP0002066_abnormal_motor_capabilities/c | 1.52258304 |
37 | MP0009780_abnormal_chondrocyte_physiolo | 1.51353863 |
38 | MP0004145_abnormal_muscle_electrophysio | 1.49912047 |
39 | MP0004885_abnormal_endolymph | 1.42854419 |
40 | MP0003633_abnormal_nervous_system | 1.42355473 |
41 | MP0004142_abnormal_muscle_tone | 1.40431800 |
42 | MP0000955_abnormal_spinal_cord | 1.40388237 |
43 | MP0008872_abnormal_physiological_respon | 1.31624353 |
44 | MP0002882_abnormal_neuron_morphology | 1.28105237 |
45 | MP0001188_hyperpigmentation | 1.27538115 |
46 | MP0003631_nervous_system_phenotype | 1.25738873 |
47 | MP0000778_abnormal_nervous_system | 1.25400836 |
48 | MP0000013_abnormal_adipose_tissue | 1.22731332 |
49 | MP0004858_abnormal_nervous_system | 1.22487614 |
50 | MP0001502_abnormal_circadian_rhythm | 1.20691719 |
51 | MP0001348_abnormal_lacrimal_gland | 1.18886750 |
52 | MP0008874_decreased_physiological_sensi | 1.08273366 |
53 | MP0004742_abnormal_vestibular_system | 1.06653164 |
54 | MP0003787_abnormal_imprinting | 1.05267732 |
55 | MP0003632_abnormal_nervous_system | 1.05196327 |
56 | MP0002152_abnormal_brain_morphology | 1.03519593 |
57 | MP0001905_abnormal_dopamine_level | 1.02988142 |
58 | MP0002069_abnormal_eating/drinking_beha | 0.94886487 |
59 | MP0002229_neurodegeneration | 0.94466138 |
60 | MP0001177_atelectasis | 0.94403624 |
61 | MP0001346_abnormal_lacrimal_gland | 0.94053988 |
62 | MP0003690_abnormal_glial_cell | 0.91863040 |
63 | MP0004085_abnormal_heartbeat | 0.91128033 |
64 | MP0000751_myopathy | 0.89416253 |
65 | MP0000920_abnormal_myelination | 0.88737644 |
66 | MP0003075_altered_response_to | 0.87556409 |
67 | MP0003283_abnormal_digestive_organ | 0.87292038 |
68 | MP0000604_amyloidosis | 0.85690430 |
69 | MP0004215_abnormal_myocardial_fiber | 0.84741912 |
70 | MP0005535_abnormal_body_temperature | 0.81952200 |
71 | MP0006276_abnormal_autonomic_nervous | 0.78797444 |
72 | MP0005623_abnormal_meninges_morphology | 0.78199806 |
73 | MP0005167_abnormal_blood-brain_barrier | 0.77747020 |
74 | MP0001485_abnormal_pinna_reflex | 0.76608614 |
75 | MP0005551_abnormal_eye_electrophysiolog | 0.76232293 |
76 | MP0003137_abnormal_impulse_conducting | 0.76013654 |
77 | MP0004043_abnormal_pH_regulation | 0.75909583 |
78 | MP0001963_abnormal_hearing_physiology | 0.75476601 |
79 | MP0008877_abnormal_DNA_methylation | 0.73991827 |
80 | MP0004484_altered_response_of | 0.73285792 |
81 | MP0004147_increased_porphyrin_level | 0.71919082 |
82 | MP0005409_darkened_coat_color | 0.70728118 |
83 | MP0008961_abnormal_basal_metabolism | 0.69995538 |
84 | MP0005645_abnormal_hypothalamus_physiol | 0.68169416 |
85 | MP0002090_abnormal_vision | 0.65240470 |
86 | MP0005499_abnormal_olfactory_system | 0.64820787 |
87 | MP0005394_taste/olfaction_phenotype | 0.64820787 |
88 | MP0001986_abnormal_taste_sensitivity | 0.64809213 |
89 | MP0002638_abnormal_pupillary_reflex | 0.63796138 |
90 | MP0003634_abnormal_glial_cell | 0.63358780 |
91 | MP0000579_abnormal_nail_morphology | 0.60310956 |
92 | MP0002837_dystrophic_cardiac_calcinosis | 0.59757090 |
93 | MP0004510_myositis | 0.58525570 |
94 | MP0002876_abnormal_thyroid_physiology | 0.58339601 |
95 | MP0003172_abnormal_lysosome_physiology | 0.58130179 |
96 | MP0004233_abnormal_muscle_weight | 0.58003872 |
97 | MP0002752_abnormal_somatic_nervous | 0.57027831 |
98 | MP0004130_abnormal_muscle_cell | 0.56386108 |
99 | MP0000569_abnormal_digit_pigmentation | 0.55152814 |
100 | MP0010234_abnormal_vibrissa_follicle | 0.54710323 |
101 | MP0005166_decreased_susceptibility_to | 0.54634195 |
102 | MP0003122_maternal_imprinting | 0.54449063 |
103 | * MP0010769_abnormal_survival | 0.53509838 |
104 | MP0003646_muscle_fatigue | 0.53483899 |
105 | MP0010386_abnormal_urinary_bladder | 0.53206237 |
106 | MP0003956_abnormal_body_size | 0.52022565 |
107 | * MP0010768_mortality/aging | 0.50674475 |
108 | * MP0010770_preweaning_lethality | 0.50020529 |
109 | * MP0002082_postnatal_lethality | 0.50020529 |
110 | MP0001943_abnormal_respiration | 0.49049646 |
111 | MP0003045_fibrosis | 0.48963491 |
112 | MP0002089_abnormal_postnatal_growth/wei | 0.47368555 |
113 | MP0002249_abnormal_larynx_morphology | 0.47252643 |
114 | MP0002873_normal_phenotype | 0.46537459 |
115 | MP0001765_abnormal_ion_homeostasis | 0.45253501 |
116 | MP0002169_no_abnormal_phenotype | 0.44924890 |
117 | MP0000639_abnormal_adrenal_gland | 0.43628149 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Focal motor seizures (HP:0011153) | 9.11739050 |
2 | Myokymia (HP:0002411) | 7.37178624 |
3 | Focal seizures (HP:0007359) | 6.54373316 |
4 | Atonic seizures (HP:0010819) | 5.81680592 |
5 | Visual hallucinations (HP:0002367) | 5.56682046 |
6 | Febrile seizures (HP:0002373) | 5.37660162 |
7 | Action tremor (HP:0002345) | 5.33094801 |
8 | Epileptic encephalopathy (HP:0200134) | 5.32717399 |
9 | Progressive cerebellar ataxia (HP:0002073) | 5.17571777 |
10 | Gaze-evoked nystagmus (HP:0000640) | 4.95108454 |
11 | Absence seizures (HP:0002121) | 4.78338948 |
12 | Dysdiadochokinesis (HP:0002075) | 4.38065034 |
13 | Dialeptic seizures (HP:0011146) | 4.36805152 |
14 | Dysmetric saccades (HP:0000641) | 4.31377394 |
15 | Broad-based gait (HP:0002136) | 4.31068204 |
16 | Generalized tonic-clonic seizures (HP:0002069) | 4.08795109 |
17 | Poor eye contact (HP:0000817) | 4.08372833 |
18 | Cerebral hypomyelination (HP:0006808) | 4.06611397 |
19 | Scanning speech (HP:0002168) | 4.06081943 |
20 | Impaired smooth pursuit (HP:0007772) | 3.76505905 |
21 | Abnormal social behavior (HP:0012433) | 3.74090884 |
22 | Impaired social interactions (HP:0000735) | 3.74090884 |
23 | Dysmetria (HP:0001310) | 3.62006703 |
24 | Truncal ataxia (HP:0002078) | 3.51727544 |
25 | Depression (HP:0000716) | 3.37606373 |
26 | Hemiplegia (HP:0002301) | 3.36858880 |
27 | Hyperventilation (HP:0002883) | 3.36534189 |
28 | Anxiety (HP:0000739) | 3.33685443 |
29 | Abnormality of ocular smooth pursuit (HP:0000617) | 3.33597992 |
30 | Status epilepticus (HP:0002133) | 3.30553092 |
31 | Intention tremor (HP:0002080) | 3.26389302 |
32 | Impaired vibration sensation in the lower limbs (HP:0002166) | 3.19836827 |
33 | Genetic anticipation (HP:0003743) | 3.15941847 |
34 | Abnormality of the lower motor neuron (HP:0002366) | 3.12693199 |
35 | Hemiparesis (HP:0001269) | 3.05169389 |
36 | Diplopia (HP:0000651) | 3.04339508 |
37 | Abnormality of binocular vision (HP:0011514) | 3.04339508 |
38 | Ankle clonus (HP:0011448) | 2.97338441 |
39 | Akinesia (HP:0002304) | 2.83203340 |
40 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.83167537 |
41 | Ventricular fibrillation (HP:0001663) | 2.81019571 |
42 | Postural instability (HP:0002172) | 2.80876793 |
43 | Tetraplegia (HP:0002445) | 2.79356904 |
44 | Torticollis (HP:0000473) | 2.77497101 |
45 | Apathy (HP:0000741) | 2.66902096 |
46 | Amblyopia (HP:0000646) | 2.66763520 |
47 | Resting tremor (HP:0002322) | 2.65770976 |
48 | Sleep apnea (HP:0010535) | 2.64928143 |
49 | Focal dystonia (HP:0004373) | 2.62790053 |
50 | Progressive inability to walk (HP:0002505) | 2.60534936 |
51 | Mutism (HP:0002300) | 2.60110442 |
52 | Insomnia (HP:0100785) | 2.60054884 |
53 | Supranuclear gaze palsy (HP:0000605) | 2.59880689 |
54 | Choreoathetosis (HP:0001266) | 2.54191136 |
55 | * Stereotypic behavior (HP:0000733) | 2.51366218 |
56 | Abnormality of saccadic eye movements (HP:0000570) | 2.49611820 |
57 | Peripheral hypomyelination (HP:0007182) | 2.48540817 |
58 | Fetal akinesia sequence (HP:0001989) | 2.46172169 |
59 | Spastic gait (HP:0002064) | 2.44918725 |
60 | Epileptiform EEG discharges (HP:0011182) | 2.43703409 |
61 | Bradykinesia (HP:0002067) | 2.43559048 |
62 | Impaired vibratory sensation (HP:0002495) | 2.42576220 |
63 | Bundle branch block (HP:0011710) | 2.42483782 |
64 | CNS hypomyelination (HP:0003429) | 2.42218767 |
65 | Diminished motivation (HP:0000745) | 2.41582786 |
66 | Urinary urgency (HP:0000012) | 2.39892689 |
67 | Craniofacial dystonia (HP:0012179) | 2.31695421 |
68 | Drooling (HP:0002307) | 2.28890216 |
69 | Excessive salivation (HP:0003781) | 2.28890216 |
70 | Gait ataxia (HP:0002066) | 2.28140715 |
71 | * Abnormal eating behavior (HP:0100738) | 2.25984903 |
72 | EEG with generalized epileptiform discharges (HP:0011198) | 2.25572145 |
73 | Limb ataxia (HP:0002070) | 2.25389839 |
74 | Rapidly progressive (HP:0003678) | 2.24483013 |
75 | Incomplete penetrance (HP:0003829) | 2.21260049 |
76 | Postural tremor (HP:0002174) | 2.17488861 |
77 | Neuronal loss in central nervous system (HP:0002529) | 2.16960096 |
78 | Hypsarrhythmia (HP:0002521) | 2.16430958 |
79 | Morphological abnormality of the pyramidal tract (HP:0002062) | 2.13561626 |
80 | Inability to walk (HP:0002540) | 2.11129781 |
81 | Clonus (HP:0002169) | 2.07599846 |
82 | Horizontal nystagmus (HP:0000666) | 2.06565633 |
83 | Generalized myoclonic seizures (HP:0002123) | 2.04996298 |
84 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 2.04731337 |
85 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 2.04731337 |
86 | Heart block (HP:0012722) | 2.04078495 |
87 | Abnormality of the corticospinal tract (HP:0002492) | 1.98731309 |
88 | Absent speech (HP:0001344) | 1.96391038 |
89 | Pheochromocytoma (HP:0002666) | 1.95676965 |
90 | * Annular pancreas (HP:0001734) | 1.94885885 |
91 | Lower limb amyotrophy (HP:0007210) | 1.94818307 |
92 | Amyotrophic lateral sclerosis (HP:0007354) | 1.93852699 |
93 | Memory impairment (HP:0002354) | 1.92994825 |
94 | Unsteady gait (HP:0002317) | 1.92957052 |
95 | Papilledema (HP:0001085) | 1.92402770 |
96 | * Pointed chin (HP:0000307) | 1.90136154 |
97 | Abnormal atrioventricular conduction (HP:0005150) | 1.87053802 |
98 | Aplasia involving bones of the upper limbs (HP:0009823) | 1.86946374 |
99 | Aplasia of the phalanges of the hand (HP:0009802) | 1.86946374 |
100 | Aplasia involving bones of the extremities (HP:0009825) | 1.86946374 |
101 | Abnormal EKG (HP:0003115) | 1.86924266 |
102 | Megalencephaly (HP:0001355) | 1.85260682 |
103 | Psychosis (HP:0000709) | 1.85155589 |
104 | Abnormality of the periventricular white matter (HP:0002518) | 1.82086014 |
105 | Increased circulating renin level (HP:0000848) | 1.81507562 |
106 | Dementia (HP:0000726) | 1.78786479 |
107 | Hand muscle atrophy (HP:0009130) | 1.77283020 |
108 | Rigidity (HP:0002063) | 1.75933405 |
109 | Slow saccadic eye movements (HP:0000514) | 1.75825720 |
110 | Neurofibrillary tangles (HP:0002185) | 1.75430664 |
111 | Spastic tetraparesis (HP:0001285) | 1.73162339 |
112 | Slow progression (HP:0003677) | 1.72686927 |
113 | Delusions (HP:0000746) | 1.72481731 |
114 | Lower limb muscle weakness (HP:0007340) | 1.68093291 |
115 | Ankyloglossia (HP:0010296) | 1.67860207 |
116 | Cerebral inclusion bodies (HP:0100314) | 1.67753567 |
117 | Obstructive sleep apnea (HP:0002870) | 1.67677156 |
118 | Prolonged QT interval (HP:0001657) | 1.65873260 |
119 | Limb dystonia (HP:0002451) | 1.64453631 |
120 | Neuroendocrine neoplasm (HP:0100634) | 1.63102505 |
121 | Polyphagia (HP:0002591) | 1.61642511 |
122 | Agitation (HP:0000713) | 1.60749588 |
123 | Blue irides (HP:0000635) | 1.59206818 |
124 | Specific learning disability (HP:0001328) | 1.59086667 |
125 | Cortical visual impairment (HP:0100704) | 1.58918591 |
Rank | Gene Set | Z-score |
---|---|---|
1 | EPHA4 | 5.15387997 |
2 | NTRK3 | 4.30194415 |
3 | MAP3K9 | 3.70679405 |
4 | DAPK2 | 3.09337360 |
5 | CAMKK2 | 2.72122255 |
6 | MAP3K4 | 2.69746514 |
7 | RIPK4 | 2.52045498 |
8 | CAMKK1 | 2.40783646 |
9 | MINK1 | 2.38626822 |
10 | MAP2K7 | 2.25691479 |
11 | KSR2 | 2.20263969 |
12 | CDK19 | 2.09397290 |
13 | CASK | 2.05500568 |
14 | PAK6 | 1.94161975 |
15 | NTRK2 | 1.88591941 |
16 | KSR1 | 1.86482532 |
17 | DAPK1 | 1.81910627 |
18 | PRPF4B | 1.75170961 |
19 | ARAF | 1.74150235 |
20 | MAP2K4 | 1.74137878 |
21 | MARK1 | 1.68306528 |
22 | LATS2 | 1.63649586 |
23 | PRKD3 | 1.56299640 |
24 | CDK5 | 1.50809271 |
25 | TNIK | 1.48905246 |
26 | STK38 | 1.48815474 |
27 | MAP3K13 | 1.46523800 |
28 | MAP3K12 | 1.42903874 |
29 | NTRK1 | 1.39316739 |
30 | PLK2 | 1.36739187 |
31 | PRKCG | 1.31448263 |
32 | SIK2 | 1.26631698 |
33 | FES | 1.20360294 |
34 | GRK5 | 1.18455290 |
35 | PNCK | 1.15800435 |
36 | TYRO3 | 1.13677800 |
37 | PINK1 | 1.12419453 |
38 | OXSR1 | 1.12189327 |
39 | SGK223 | 1.12112048 |
40 | SGK494 | 1.12112048 |
41 | RIPK1 | 1.11309901 |
42 | SGK2 | 1.09385828 |
43 | TAOK1 | 1.08625485 |
44 | MAP3K2 | 1.06439613 |
45 | CCNB1 | 1.05875795 |
46 | SIK3 | 1.05519941 |
47 | CDK18 | 1.02318210 |
48 | WNK1 | 1.00408558 |
49 | CDK15 | 0.97132582 |
50 | BMPR2 | 0.96692444 |
51 | CAMK1 | 0.96318867 |
52 | STK11 | 0.95645282 |
53 | PRKCH | 0.94619824 |
54 | RAF1 | 0.94101626 |
55 | SGK3 | 0.92625914 |
56 | CAMK2A | 0.89728300 |
57 | CAMK2B | 0.89083202 |
58 | CDK14 | 0.87108725 |
59 | AKT3 | 0.85202486 |
60 | CDK11A | 0.84620229 |
61 | MAPK13 | 0.78338793 |
62 | PDK1 | 0.78079379 |
63 | SGK1 | 0.76795172 |
64 | PDPK1 | 0.76580440 |
65 | UHMK1 | 0.75934090 |
66 | ALK | 0.75139688 |
67 | NEK1 | 0.75134320 |
68 | PKN1 | 0.72193595 |
69 | MAP3K11 | 0.69996184 |
70 | PTK2B | 0.67251095 |
71 | LIMK1 | 0.65803883 |
72 | CAMK4 | 0.62553541 |
73 | NEK6 | 0.61981138 |
74 | CAMK2G | 0.60955052 |
75 | RET | 0.57577666 |
76 | DYRK1A | 0.57110870 |
77 | MAP3K1 | 0.54829267 |
78 | LMTK2 | 0.54781013 |
79 | BRAF | 0.54659127 |
80 | BRSK1 | 0.54268416 |
81 | DAPK3 | 0.54185154 |
82 | RPS6KA3 | 0.54182930 |
83 | TNK2 | 0.53525569 |
84 | MARK2 | 0.52920610 |
85 | FGFR2 | 0.51376615 |
86 | TESK1 | 0.49501136 |
87 | BCR | 0.49453539 |
88 | PRKCE | 0.48029021 |
89 | ROCK2 | 0.47499669 |
90 | CAMK2D | 0.47055280 |
91 | PDK3 | 0.46253891 |
92 | PDK4 | 0.46253891 |
93 | FYN | 0.43480536 |
94 | MAP2K1 | 0.42389960 |
95 | PRKCZ | 0.38462238 |
96 | CDC42BPA | 0.37924752 |
97 | PRKG2 | 0.37518734 |
98 | PHKG2 | 0.37443257 |
99 | PHKG1 | 0.37443257 |
100 | MAPK10 | 0.37441748 |
101 | PRKACA | 0.34747366 |
102 | IRAK2 | 0.34534132 |
103 | MAPK12 | 0.34122110 |
104 | PRKCB | 0.33657493 |
105 | CSNK1A1 | 0.33498637 |
106 | MAPK7 | 0.32905326 |
107 | PRKCA | 0.32139540 |
108 | MOS | 0.28978588 |
109 | MAP2K6 | 0.28003111 |
110 | ERBB2 | 0.27900155 |
111 | CSNK1G2 | 0.27552347 |
112 | PAK3 | 0.26418609 |
113 | MAPK8 | 0.25430437 |
114 | ROCK1 | 0.25075280 |
115 | SRC | 0.24555298 |
116 | MAPKAPK5 | 0.23930579 |
117 | JAK2 | 0.22029859 |
Rank | Gene Set | Z-score |
---|---|---|
1 | * Nicotine addiction_Homo sapiens_hsa05033 | 3.97978001 |
2 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 3.42050830 |
3 | Long-term potentiation_Homo sapiens_hsa04720 | 3.00227471 |
4 | Circadian entrainment_Homo sapiens_hsa04713 | 2.85160134 |
5 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.83684627 |
6 | * Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.82669911 |
7 | Olfactory transduction_Homo sapiens_hsa04740 | 2.82151950 |
8 | * GABAergic synapse_Homo sapiens_hsa04727 | 2.81663309 |
9 | * Morphine addiction_Homo sapiens_hsa05032 | 2.69581249 |
10 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.67060284 |
11 | Salivary secretion_Homo sapiens_hsa04970 | 2.32467020 |
12 | Dopaminergic synapse_Homo sapiens_hsa04728 | 2.19569138 |
13 | Long-term depression_Homo sapiens_hsa04730 | 2.06332232 |
14 | Taste transduction_Homo sapiens_hsa04742 | 2.03154264 |
15 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.00959674 |
16 | Insulin secretion_Homo sapiens_hsa04911 | 1.85987357 |
17 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.85550174 |
18 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.85259831 |
19 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.84817552 |
20 | Cocaine addiction_Homo sapiens_hsa05030 | 1.77810849 |
21 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.71861355 |
22 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.71103219 |
23 | Renin secretion_Homo sapiens_hsa04924 | 1.69044437 |
24 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.69026123 |
25 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.64895485 |
26 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.57416825 |
27 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.49136428 |
28 | Gap junction_Homo sapiens_hsa04540 | 1.36864211 |
29 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.35845673 |
30 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.33818462 |
31 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.33103554 |
32 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.33066077 |
33 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.24954896 |
34 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.14129247 |
35 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.13068650 |
36 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.11601585 |
37 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.06666643 |
38 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.04981256 |
39 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.99250545 |
40 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.98899407 |
41 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.96471375 |
42 | * Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.96249717 |
43 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.94154227 |
44 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.91855668 |
45 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.90849721 |
46 | Glioma_Homo sapiens_hsa05214 | 0.88461010 |
47 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.87653173 |
48 | Melanogenesis_Homo sapiens_hsa04916 | 0.84042668 |
49 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.82126084 |
50 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.81441319 |
51 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.79394690 |
52 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.79059754 |
53 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.78463898 |
54 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.77893025 |
55 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.75936294 |
56 | Axon guidance_Homo sapiens_hsa04360 | 0.72683013 |
57 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.67485851 |
58 | Phototransduction_Homo sapiens_hsa04744 | 0.66990321 |
59 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.66819681 |
60 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.66661701 |
61 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.66654406 |
62 | Circadian rhythm_Homo sapiens_hsa04710 | 0.65433682 |
63 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.63577062 |
64 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.63051328 |
65 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.61810931 |
66 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.60245065 |
67 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.56212079 |
68 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.55324251 |
69 | Bile secretion_Homo sapiens_hsa04976 | 0.53775268 |
70 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.52780100 |
71 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.51817375 |
72 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.50869518 |
73 | Alcoholism_Homo sapiens_hsa05034 | 0.50121140 |
74 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.49395759 |
75 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.49357228 |
76 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.48360119 |
77 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.46895581 |
78 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.46199999 |
79 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.44735834 |
80 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.42378119 |
81 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.41160348 |
82 | Alzheimers disease_Homo sapiens_hsa05010 | 0.39343597 |
83 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.38596248 |
84 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.38041910 |
85 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.37740313 |
86 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.37731090 |
87 | Mineral absorption_Homo sapiens_hsa04978 | 0.37472654 |
88 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.37091783 |
89 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.35530991 |
90 | Endocytosis_Homo sapiens_hsa04144 | 0.35415631 |
91 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.34970403 |
92 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.33923359 |
93 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.32858594 |
94 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.32434752 |
95 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.32030804 |
96 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.30362737 |
97 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.30307143 |
98 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.30233781 |
99 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.28317338 |
100 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.27614243 |
101 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.27483541 |
102 | Prion diseases_Homo sapiens_hsa05020 | 0.26337639 |
103 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.25975517 |
104 | Histidine metabolism_Homo sapiens_hsa00340 | 0.25149955 |
105 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.24671716 |
106 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.24082397 |
107 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.23570388 |
108 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.23165917 |
109 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.22777598 |
110 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.21802133 |
111 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.19647616 |
112 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.19194098 |
113 | Tight junction_Homo sapiens_hsa04530 | 0.17282065 |
114 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.15799802 |
115 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.14790462 |